Active	Status	Sponsor type	Region	Phase	Filter
2 Active 2 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   - « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
MT1002 / Shaanxi Micot Technology
NCT04723186: MT1002 Phase II Study in ACS Patients With PCI	Terminated	2	6	US	MT1002 for Injection	Shaanxi Micot Technology Limited Company	Acute Coronary Syndrome	08/23	08/23
NCT06533358: A Clinical Study of MT1002 in Subjects With Acute Coronary Syndrome Undergoing PCI	Recruiting	2	20	RoW	MT1002 Injection, No other name	Shaanxi Micot Technology Limited Company	Acute Coronary Syndrome	12/24	07/25

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
MT1002 / Shaanxi Micot Technology
NCT04723186: MT1002 Phase II Study in ACS Patients With PCI	Terminated	2	6	US	MT1002 for Injection	Shaanxi Micot Technology Limited Company	Acute Coronary Syndrome	08/23	08/23
NCT06533358: A Clinical Study of MT1002 in Subjects With Acute Coronary Syndrome Undergoing PCI	Recruiting	2	20	RoW	MT1002 Injection, No other name	Shaanxi Micot Technology Limited Company	Acute Coronary Syndrome	12/24	07/25